Skip to main content
. 2022 Jun 3;14:914920. doi: 10.3389/fnagi.2022.914920

TABLE 2.

Patients with vertigo versus healthy controls for each microstate class.

Parameter Micostate Vertigo HC p-Value
Mean duration (ms) Class A 70.57 ± 16.02 63.62 ± 8.39 0.0129
Class B 65.52 ± 14.03 63.64 ± 10.10 0.4764
Class C 62.51 ± 24.02 67.20 ± 16.75 0.2954
Class D 69.62 ± 21.68 62.88 ± 22.19 0.1614
Time coverage (%) Class A 28.53 ± 11.46 25.19 ± 8.21 0.1229
Class B 25.02 ± 8.95 25.22 ± 7.37 0.9094
Class C 18.14 ± 12.32 27.22 ± 11.60 0.0007
Class D 28.31 ± 13.42 22.37 ± 12.70 0.0389
Occurrence Class A 4.03 ± 1.06 3.94 ± 0.97 0.6905
Class B 3.82 ± 0.85 3.97 ± 0.81 0.4029
Class C 2.74 ± 1.17 4.00 ± 1.15 <0.0001
Class D 4.01 ± 1.28 3.42 ± 1.18 0.0275

p-Values refer to unpaired t-test p-value for each parameter separately between patients with vertigo and healthy controls. Statistically significant differences are in bold.